SOLENO THERAPEUTICS
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
SOLENO THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1999-08-25
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.soleno.life
Total Employee:
11+
Status:
Active
Contact:
(650) 213-8444
Total Funding:
31.5 M USD
Similar Organizations
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Current Advisors List
Board_member
Current Employees Featured
Anish Bhatnagar Chief Executive Officer, President & Chief Operating Officer @ Soleno Therapeutics
Chief Executive Officer, President & Chief Operating Officer
2017-01-01
Jim Mackaness Chief Financial Officer @ Soleno Therapeutics
Chief Financial Officer
Birgitte Volck Non Executive Director @ Soleno Therapeutics
Non Executive Director
2019-06-01
Stock Details
Investors List
Jack Schuler
Jack Schuler investment in Post-IPO Equity - Soleno Therapeutics
Ernest Mario
Ernest Mario investment in Post-IPO Equity - Soleno Therapeutics
Abingworth
Abingworth investment in Post-IPO Equity - Soleno Therapeutics
Oracle Investment Management Inc.
Oracle Investment Management Inc. investment in Post-IPO Equity - Soleno Therapeutics
Official Site Inspections
http://www.soleno.life Semrush global rank: 3.66 M Semrush visits lastest month: 3.87 K
- Host name: 145.0.153.160.host.secureserver.net
- IP address: 160.153.0.145
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Soleno Therapeutics"
About Us – Soleno Therapeutics
We are soleno. Inspired by patients and families around the world, we are working to develop and commercialize novel and much needed therapeutics to treat rare genetic disorders. We are committed to making a positive difference in the …See details»
Team – Soleno Therapeutics
Prior to Soleno, Dr. Bhatnagar served as Chief Executive Officer of Capnia, Inc from February 2014 until March 2017, and held positions of increasing responsibility at Capnia from 2006 . ...See details»
Notre implication : Engagement social et environnemental - Soleno
Soleno is actively involved in L’Étoile, pédiatrie sociale an organization which provides services to more than 200 children aged 0 to 14 at risk or in vulnerable situations to ensure their well …See details»
Investor Relations – Soleno Therapeutics Inc.
Jan 29, 2025 Soleno Therapeutics Inc. provides investor relations information for a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases.See details»
Soleno Therapeutics’ ‘life-changing’ rare-disease drug …
5 days ago The Food and Drug Administration on Wednesday approved the first medicine to treat people with Prader-Willi syndrome, a rare genetic disease that causes an insatiable desire to eat.See details»
Soleno Therapeutics - Crunchbase Company Profile
Organization. Soleno Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@soleno.life; Phone Number (650) 213-8444; Soleno Therapeutics …See details»
Soleno Therapeutics eyes FDA approval, Medicaid coverage of …
6 days ago The final steps of a Bay Area company's nine-year journey to deliver a drug to patients with a life-threatening eating disorder may rest on the Trump Administration's ongoing …See details»
Soleno Therapeutics Provides Corporate Update and Reports …
REDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for …See details»
Soleno Therapeutics’ ‘life-changing’ drug nears approval decision
Mar 13, 2025 Soleno's "life-changing" drug nears approval decision. It stands a very good chance of winning approval.See details»
For Patients and Families – Soleno Therapeutics
Soleno actively collaborates with advocacy groups and families to advance awareness and advocacy in the PWS community. For many individuals affected by PWS, the reduction of …See details»
Growing the next generation of farmers - Soleno
In 2025, Soleno is proud to partner with Canada’s Oustanding Young Farmers to grow the next generation. By purchasing a roll (maxi) of 4000 feet of green drain, you contribute $60 to …See details»
Soleno Therapeutics, Inc. (SLNO) - Yahoo Finance Canada
See the company profile for Soleno Therapeutics, Inc. (SLNO) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
SEC Filing – Soleno Therapeutics Inc. - investors.soleno.life
Soleno Therapeutics, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 834203309 (CUSIP Number) September 30, 2024 (Date of Event Which Requires …See details»
Tiny Drugmaker Soars on FDA Win to Treat Never-Ending Hunger
4 days ago Soleno Therapeutics jumped on Thursday after the drugmaker won US approval for its drug to treat insatiable hunger caused by a genetic disorder.. Shares of the Redwood City, …See details»
Soleno Therapeutics Provides Corporate Update and Reports …
Feb 27, 2025 Soleno is obligated to make cash payments of up to a maximum of $21.2 million to the former Essentialis stockholders upon the achievement of certain commercial milestones …See details»
Careers – Soleno Therapeutics
An equal opportunity employer. As an equal opportunity employer, Soleno Therapeutics, Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection …See details»
Soleno
Les infrastructures de demain nécessitent une approche sur mesure réfléchie. Soleno trace l’avenir avec le PEHD, une solution de rechange à l’utilisation du béton plus performante, …See details»
Soleno Therapeutics Announces Presentations at ENDO 2022
Soleno Therapeutics Announces Presentations at ENDO 2022 June 7, 2022 REDWOOD CITY, Calif. , June 07, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. ( Soleno ) …See details»
Environmental leadership - Soleno
Mobilizing know-how to recover residual plastic materials. The Soleno innovation Pole was created in 2019 with the objective of attracting and federating multidisciplinary expertise in …See details»
Our industrial sites - Soleno
Soleno has been operating in the United States since 2024. Inaugurated in September 2024, the first plant was built in the United States, confirming the company’s momentum and …See details»